Replies to post #38036 on Genta, Inc (fka GNTAQ)

[King Shaka]

I wouldn't say that. After everything I have read, I think that the the FDA and EMEA were correct in requesting that Genta fine tune their studies. I don't think they give a crap about stockholders and they shouldn't, but I do think they have a responsibility to make sure that drug makers actually hit the mark before they let them go and use their new magic drugs all over the place. I believe that Gentas studies have showed them everything they needed to know to make AGENDA a successful trial. I believe it will be successful. Worrying about the FDA's potential for corruption will cause you to make bad decisions, in my opinion. If we get great results, this drug passes. IMO.

Shakalackin

[Learner09]

Just curious as to how big FDA approval will be?

In every ones opinion. Say we're at $10 and then get approved, what do you think? Bump to $15 overnight. I know they deny and back to sub-penny most likely.

I also know a lot of factors will have to be considered. Do we have a partner, Is the data for PFS good or great.

I think if data for PFS is great we will partner for distribution prior to FDA and the price will reflect clost to after approval price due to the fact the writing is on the wall.

If data is not so great for PFS we get a bump in price a few bucks and no partner till after FDA's decision and it could go either way.

Much greater gamble on second scenario. Just board and thinking out loud.

Learner.